首页> 外文期刊>Journal of chromatography, A: Including electrophoresis and other separation methods >9-Plex ultra high performance liquid chromatography tandem mass spectrometry determination of free hydroxyl polycyclic aromatic hydrocarbons in human plasma and urine
【24h】

9-Plex ultra high performance liquid chromatography tandem mass spectrometry determination of free hydroxyl polycyclic aromatic hydrocarbons in human plasma and urine

机译:9-PLEX超高效液相色谱串联质谱法测定人血浆和尿液中游离羟基多环芳烃

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hydroxyl-polycyclic aromatic hydrocarbons (OH-PAHs) are biomarkers for assessing the exposure levels of polycyclic aromatic hydrocarbons (PAHs). A series of stable isotope mass tags (SIMT-332/338/346/349/351/354/360/363/374/377) were firstly designed and synthesized to perform multiplexed stable isotope labeling derivatization (MSILD) of OH-PAHs in human plasma and urine. Their derivatives were enriched and purified by magnetic dispersive solid phase extraction (MDSPE) using prepared Fe3O4/GO and then determined by ultra high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) in multiple reaction monitoring mode. 9-Plexed MSILD reagents were prepared using pipemidic acid as core structure with different isotope mass tags, in which carbonyl chloride group was used to label OH-PAHs. The SIMT-346 labeled OH-PAHs standards were used as internal standards, which can greatly increase the quantitative accuracy. 9-Plex labeled nine different real samples can be quantified by UHPLC-MS/MS in a single run. Under optimized MSILD-MDSPE conditions, good linearities of seven OH-PAHs were obtained with satisfactory coefficient of determination R-2 > 0.991. Limits of detection (LODs) of seven OH-PAHs were from 0.1 to 0.5 pg/mL, and limits of quantitation (LOQs) ranged from 0.5 to 2.0 pg/mL. The intra- and inter-day precisions ranged in 2.3-12.4% with accuracies in the range of 91.7-108.4%. Acceptable results of matrix effect (89.7-105.7%) and derivatization efficiency (> 96.4%) were obtained. In short, the developed method has been proved to be high-throughput, sensitive, accurate and easy-handling. This method was applied for the measurement of seven free OH-PAHs in human urine and plasma, and expected to provide technical support for the evaluation of PAHs exposure levels in humans. (C) 2020 Elsevier B.V. All rights reserved.
机译:羟 - 多环芳烃(OH-PAHS)是用于评估多环芳烃(PAH)的曝光水平的生物标志物。首先设计和合成了一系列稳定同位素质量标签(SIMT-332 / 338/346 / 349/351/354/360 / 363/374 / 367),以进行OH-PAHS的多路复用稳定同位素标记衍生化(MSILD)人血浆和尿液。通过使用制备的Fe3O4 /去,通过磁性色散固相萃取(MDSPE)富集和纯化它们的衍生物,然后通过多重反应监测模式通过超高效液相色谱串联质谱(UHPLC-MS / MS)测定。使用亚磷酸作为核心结构制备9-络合物的微小试剂,作为具有不同同位素质量标签的核心结构,其中使用羰基氯基团标记OH-PAHS。 SIMT-346标记为OH-PAHS标准作为内部标准,可以大大提高定量精度。 9-Plex标记为九个不同的真实样品,可以通过单次运行通过UHPLC-MS / MS量化。在优化的MSID-MDSPE条件下,获得七个OH-PAHs的良好线性,令人满意的测定系数R-2> 0.991。七OH-PAH的检测限(LOD)为0.1至0.5pg / ml,并且定量限制(LOQ)的限制范围为0.5至2.0pg / ml。内部和日内的诊断在2.3-12.4%的范围内,可准确度为91.7-108.4%。获得的基质效应的可接受结果(89.7-105.7%)和衍生化效率(> 96.4%)。简而言之,已被证明的开发方法是高吞吐量,灵敏,准确且易于处理。该方法用于测量人类尿液和等离子体中的七种免费OH-PAHS,并预计为评估人类的PAHS暴露水平提供技术支持。 (c)2020 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号